相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nuclear localization and phosphorylation modulate pathological effects of alpha-synuclein
Raquel Pinho et al.
HUMAN MOLECULAR GENETICS (2019)
Modifiable risk factors for cognitive impairment in Parkinson's disease: A systematic review and meta-analysis of prospective cohort studies
Yu Guo et al.
MOVEMENT DISORDERS (2019)
Pathogenic alpha-synuclein aggregates preferentially bind to mitochondria and affect cellular respiration
Xinhe Wang et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa)
Brit Mollenhauer et al.
MOVEMENT DISORDERS (2019)
A shared comparison of diabetes mellitus and neurodegenerative disorders
Mahmoud Morsi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Biochemical and cellular properties of insulin receptor signalling
Rebecca A. Haeusler et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums
Steven E. Arnold et al.
NATURE REVIEWS NEUROLOGY (2018)
Association between diabetes and subsequent Parkinson disease A record-linkage cohort study
Eduardo De Pablo-Fernandez et al.
NEUROLOGY (2018)
α-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson's disease
Marthe H. R. Ludtmann et al.
NATURE COMMUNICATIONS (2018)
Altered mitochondrial function in insulin-deficient and insulin-resistant states
Gregory N. Ruegsegger et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Links Between Obesity-Induced Brain Insulin Resistance, Brain Mitochondrial Dysfunction, and Dementia
Jirapas Sripetchwandee et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
Dilan Athauda et al.
LANCET (2017)
A Human Neural Crest Stem Cell-Derived Dopaminergic Neuronal Model Recapitulates Biochemical Abnormalities in GBA1 Mutation Carriers
Shi-Yu Yang et al.
STEM CELL REPORTS (2017)
Mitochondrial dynamics in Parkinson's disease: a role for α-synuclein?
Victorio M. Pozo Devoto et al.
DISEASE MODELS & MECHANISMS (2017)
Is Alzheimer's disease a Type 3 Diabetes? A critical appraisal
Ramesh Kandimalla et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)
Accumulation of α-Synuclein in Cerebellar Purkinje Cells of Diabetic Rats and Its Potential Relationship with Inflammation and Oxidative Stress Markers
Volkan Solmaz et al.
NEUROLOGY RESEARCH INTERNATIONAL (2017)
Effects of Serine 129 Phosphorylation on α-Synuclein Aggregation, Membrane Association, and Internalization
Filsy Samuel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Mitochondrial and lysosomal biogenesis are activated following PINK1/parkin-mediated mitophagy
Davor Ivankovic et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Brain Insulin Signaling Is Increased in Insulin-Resistant States and Decreases in FOXOs and PGC-1α and Increases in Aβ1-40/42 and Phospho-Tau May Abet Alzheimer Development
Mini Sajan et al.
DIABETES (2016)
PGC-1α, glucose metabolism and type 2 diabetes mellitus
Haijiang Wu et al.
JOURNAL OF ENDOCRINOLOGY (2016)
α-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson's disease
Roberto Di Maio et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
The Cytomegalovirus protein pUL37x1 targets mitochondria to mediate neuroprotection
Chien Tai Hong et al.
SCIENTIFIC REPORTS (2016)
An Overview of Murine High Fat Diet as a Model for Type 2 Diabetes Mellitus
Ahlke Heydemann
JOURNAL OF DIABETES RESEARCH (2016)
A novel link between the conformations, exposure of specific epitopes, and subcellular localization of α-synuclein
Min-Kyung Nam et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2015)
Biomarkers of insulin sensitivity and insulin resistance: Past, present and future
Se Eun Park et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2015)
The phosphorylation of α-synuclein: development and implication for the mechanism and therapy of the Parkinson's disease
Yan Xu et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations
Benjamin Dehay et al.
LANCET NEUROLOGY (2015)
Type 2 diabetes mellitus
Ralph A. DeFronzo et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Neuroinflammation in Parkinson's disease and its potential as therapeutic target
Qinqin Wang et al.
TRANSLATIONAL NEURODEGENERATION (2015)
Polo-like kinase 2 activates an antioxidant pathway to promote the survival of cells with mitochondrial dysfunction
Jie Li et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Imaging insights into basal ganglia function, Parkinson's disease, and dystonia
A. Jon Stoessl et al.
LANCET (2014)
Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives
Anthony H. V. Schapira et al.
LANCET (2014)
Diabetes and Risk of Parkinson's Disease: An Updated Meta-Analysis of Case-Control Studies
Lin Lu et al.
PLOS ONE (2014)
Quantitative Analysis of Histological Staining and Fluorescence Using ImageJ
Ellen C. Jensen
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2013)
Endogenous alpha-synuclein influences the number of dopaminergic neurons in mouse substantia nigra
Pablo Garcia-Reitboeck et al.
EXPERIMENTAL NEUROLOGY (2013)
Exenatide and the treatment of patients with Parkinson's disease
Iciar Aviles-Olmos et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Polo-like kinase 2 regulates selective autophagic α-synuclein clearance and suppresses its toxicity in vivo
Abid Oueslati et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Analysis of In Vitro Insulin-Resistance Models and Their Physiological Relevance to In Vivo Diet-Induced Adipose Insulin Resistance
Kinyui Alice Lo et al.
CELL REPORTS (2013)
Risk of Parkinson Disease Onset in Patients With Diabetes A 9-year population-based cohort study with age and sex stratifications
Yu Sun et al.
DIABETES CARE (2012)
Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2
K. D. Copps et al.
DIABETOLOGIA (2012)
Insulin resistance in the nervous system
Bhumsoo Kim et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)
Mitochondrial defect and PGC-1α dysfunction in parkin-associated familial Parkinson's disease
Consiglia Pacelli et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Association of PGC-1alpha polymorphisms with age of onset and risk of Parkinson's disease
Joanne Clark et al.
BMC MEDICAL GENETICS (2011)
PARIS (ZNF746) Repression of PGC-1α Contributes to Neurodegeneration in Parkinson's Disease
Joo-Ho Shin et al.
CELL (2011)
Diabetes and the Risk of Developing Parkinson's Disease in Denmark
Eva Schernhammer et al.
DIABETES CARE (2011)
Neurodegeneration in an animal model of Parkinson's disease is exacerbated by a high-fat diet
Jill K. Morris et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2010)
Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention
Malu G. Tansey et al.
NEUROBIOLOGY OF DISEASE (2010)
PGC-1α, A Potential Therapeutic Target for Early Intervention in Parkinson's Disease
Bin Zheng et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Polo-like Kinase 2 (PLK2) Phosphorylates α-Synuclein at Serine 129 in Central Nervous System
Kelly J. Inglis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The MitoPark Mouse - An animal model of Parkinson's disease with impaired respiratory chain function in dopamine neurons
Mats Ekstrand et al.
PARKINSONISM & RELATED DISORDERS (2009)
Polo-like kinases mediate cell survival in mitochondrial dysfunction
Takumi Matsumoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Type 2 diabetes and the risk of Parkinson's disease
Gang Hu et al.
DIABETES CARE (2007)
Risk of dementia in diabetes mellitus: a systematic review
GJ Biessels et al.
LANCET NEUROLOGY (2006)
分享论文
